Athebio enables innovative drug developers to create superior targeted therapeutics of advanced efficacy and safety by providing them with tailor-made “plug and play” DARPins as building blocks, working together in a co-creative space, and supporting them with in-depth expertise.
| Website | https://www.athebio.com |
| Employees | 22 (20 on RocketReach) |
| Founded | 2019 |
| Address | Grabenstrasse 11a, Schlieren, Zurich 8952, CH |
| Industry | Biotechnology |
| Keywords | Targeted Therapeutics, Plug And Play, Drug Development, Drug Discovery, Biotechnology, Therapeutic Proteins, Protein Engineering, Advanced Therapeutics, Drug Design, Building Blocks, Pharmaceutical, Biopharma, Biotechnology Tools, Therapeutic Antibodies, Precision Medicine, Molecular Biology, Pharmaceutical Research, Biologics |
| Competitors | AstraZeneca, Regeneron, Elekta, BioMarin Pharmaceutical Inc., Celerion, Zymeworks Inc., Aldevron, Medicago, Biologics Consulting, Geno +38 more (view full list) |
Looking for a particular Athebio AG employee's phone or email?
Thomas Huber is the CEO of Athebio AG.
20 people are employed at Athebio AG.
Athebio AG is based in Schlieren, Zurich.